Korbinian Löbmann

Korbinian Löbmann serves as Associate Professor in the Department of Pharmacy at the University of Copenhagen's Faculty of Health and Medical Sciences since April 2017, following his appointment as Assistant Professor in 2013. His expertise centers on advanced pharmaceutical formulation strategies to address challenges with poorly soluble drugs through novel drug delivery systems.

His educational foundation includes:

• PhD from University of Otago, New Zealand (2010-2013)
• Pharmacist registration in Munich, Germany (2010)
• Postgraduate Certificate in Pharmacy, University of Otago (2009)
• Pharmacy studies at Ludwig Maximilian University, Munich (2004-2008)

Dr. Löbmann's research pioneers enabling formulations using innovative excipients like deep eutectic solvents (DES) and cellulose nanofibers (CNF), alongside advanced strategies such as co-amorphous systems and microwave-induced in situ amorphization. This work directly targets improved drug efficacy for compounds with low solubility, combining physico-chemical characterization with practical therapeutic applications.

Analysis of his 128+ research outputs (including 8 recent publications from 2023-2024) reveals consistent focus on protein-based amorphous solid dispersions, particularly examining β-lactoglobulin systems. Key trends include investigating protein secondary structure effects on stability/dissolution, developing thermolytic salt-assisted microwave techniques, and comparative studies of dissolution enhancement approaches for drugs like rifaximin.

Recognition includes:

• Health Sciences Divisional List of Exceptional theses for PhD work

As an active academic leader, he has chaired international conferences including the Pharmaceutical Solid State Research Cluster meeting (130 participants) and NordForsk Researcher Networking Meeting (74 participants). He serves as Collection Editor for the 'Poorly Soluble Drugs' topical collection in Molecules journal and has presented at 10+ national/international forums including the Global Drug Delivery Summit in Berlin.

His research group maintains extensive international collaborations in pharmaceutical solid-state science, evidenced by multi-country co-authorship networks and editorial leadership in specialized drug delivery domains.